Literature DB >> 2110534

A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick disease.

R Weiler1, H Lassmann, P Fischer, K Jellinger, H Winkler.   

Abstract

Chromogranin A and synaptin/synaptophysin were characterized by immunological methods in human autopsy brain tissue from patients with Alzheimer's and Pick's disease. In immunoblots there was no qualitative difference between the antigens in control and diseased brain, but significant quantitative differences were found. In all Alzheimer cases there was a significantly lower level of synaptin/synaptophysin, whereas chromogranin A was higher in 4 out of 5 cases and in all cases relative to synaptin/synaptophysin. An analogous finding was obtained for Pick's disease. Immunohistologically a consistent staining of neuritic plaques for chromogranin A, but not for secretogranin II was found in Alzheimer cases. In Pick's disease the characteristic Pick bodies showed an analogous specific immunostaining.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110534     DOI: 10.1016/0014-5793(90)81408-g

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

Review 1.  Corticonigral degeneration with neuronal achromasia and basal neurofibrillary tangles.

Authors:  W Paulus; M Selim
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 2.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

3.  Tangle-associated neuritic clusters. A new lesion in Alzheimer's disease and aging suggests that aggregates of dystrophic neurites are not necessarily associated with beta/A4.

Authors:  D G Munoz; D Wang
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

4.  Aberrant GAP-43 gene expression in Alzheimer's disease.

Authors:  S M de la Monte; S C Ng; D W Hsu
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 5.  Diagnostic confirmation, severity, and subtypes of Alzheimer's disease. A short review on clinico-pathological correlations.

Authors:  H Förstl; P Fischer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

6.  Leptin signaling and Alzheimer's disease.

Authors:  Gurdeep Marwarha; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

7.  Cerebrospinal fluid levels of chromogranin A in the treatment-naïve early stage Parkinson's disease: a pilot study.

Authors:  Michaela Kaiserová; Hana Přikrylová Vranová; David Stejskal; Kateřina Menšíková; Petr Kaňovský
Journal:  J Neural Transm (Vienna)       Date:  2013-04-16       Impact factor: 3.575

8.  Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons.

Authors:  O Yasuhara; A Matsuo; I Tooyama; H Kimura; E G McGeer; P L McGeer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus.

Authors:  E Masliah; W G Honer; M Mallory; M Voigt; P Kushner; L Hansen; R Terry
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.

Authors:  Martijn C de Wilde; Cassia R Overk; John W Sijben; Eliezer Masliah
Journal:  Alzheimers Dement       Date:  2016-01-14       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.